Co-Director of the Duke Division of Artificial Intelligence and Computational Pathology Carolyn Glass, MD, PhD, gave a graduate student seminar lecture and visited with MD, PhD, and post-doctorate students at the California Institute of Technology (Caltech) in Pasadena, California, from Nov. 18-19, 2024.
Glass presented a talk titled “Artificial Intelligence and Computational Pathology Projects within Duke Medical Center.” She covered a range of topics, including cardiac transplant reperfusion injury and immune lung cancer therapy for future collaborative educational, mentoring and clinical/translational research efforts.
Changhuei Yang, PhD, Thomas G. Myers Professor of Electrical Engineering, Bioengineering, and Medical Engineering, chair of Electrical Engineering at California Institute of Technology invited Glass to Caltech for the presentation and visit. Yang is a world-renown expert in optical coherence tomography (OCT), a non-invasive imaging technique that uses light to create cross-sectional images of tissue.
One of the important missions of Duke’s Division of Artificial Intelligence (AI) and Computational Pathology is to develop AI technologies for enhancement of diagnosis; classification; prediction; and prognostication of a variety of diseases, including cancer, medical diseases, and transplantation. The eventual goal for these novel AI applications is to improve patient care. Dr. Glass noted, “Multi-institutional collaborations are critical to validation of AI algorithms. You want to test over and over again with multiple algorithm revisions and updates to ensure the algorithm performs exceptionally before clinical implementation. It takes years before all the hard work comes to fruition.”